In addition, FHL3 shows high expression in gastric cancer, glioma stem cells, pancreatic ductal adenocarcinoma, non‐small cell lung cancer T-cell leukemia, A673 neuroepithelioma cells, and tumor angiogenesis. This evidence concerns the gene FHL3 and glioma.